Shares in Roche rise as COVID-19 tests offset slump in drug sales
Demand for pharmaceutical giant Roche’s COVID-19 tests helped to offset a decline in its core drugs business, the company said on Wednesday, as it reported sales for the first quarter of 2021 and confirmed its outlook for the year
Comments